MTOR and pulmonary arterial hypertension: With liquid and gas chromatography-based mass spectrometry, a metabolomic study of human microvascular pulmonary arterial vascular smooth muscle cells was conducted in idiopathic PAH (Group 1) individuals before and following therapy with the selective adenosine triphosphate-competitive mTOR inhibitor PP242.